10x Genomics Inc (TXG)
25.00
-0.60
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
25.00
0.00 (0.00%)
After-Hours: 20:00
10x Genomics Cash from Operations (Quarterly): -15.72M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -15.72M |
| December 31, 2023 | 25.76M |
| September 30, 2023 | -25.30M |
| June 30, 2023 | -11.53M |
| March 31, 2023 | -4.125M |
| December 31, 2022 | 13.72M |
| September 30, 2022 | -9.564M |
| June 30, 2022 | -16.96M |
| March 31, 2022 | -20.80M |
| December 31, 2021 | 5.805M |
| September 30, 2021 | -26.22M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.12M |
| March 31, 2021 | -4.082M |
| December 31, 2020 | -130.18M |
| September 30, 2020 | -55.63M |
| June 30, 2020 | -29.52M |
| March 31, 2020 | -2.576M |
| December 31, 2019 | 6.70M |
| September 30, 2019 | 14.53M |
| June 30, 2019 | 4.083M |
| March 31, 2019 | 9.318M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-130.18M
Minimum
Dec 2020
25.76M
Maximum
Dec 2023
-13.92M
Average
-6.844M
Median
Cash from Operations (Quarterly) Benchmarks
| Teladoc Health Inc | 8.92M |
| American Shared Hospital Services | -3.06M |
| Novo Integrated Sciences Inc | -1.714M |
| Astrana Health Inc | 5.977M |
| Cryo-Cell International Inc | -0.3569M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 10.63M |
| Cash from Financing (Quarterly) | 1.638M |
| Free Cash Flow | -73.95M |
| Free Cash Flow Per Share (Quarterly) | -0.1561 |
| Free Cash Flow to Equity (Quarterly) | -18.64M |
| Free Cash Flow to Firm (Quarterly) | -18.64M |
| Free Cash Flow Yield | -2.50% |